Related Experiment Video
Updated: Jun 22, 2025
08:55
The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
Published on: November 30, 2016
16.2K
Assessing cachexia in obesity: contradiction or perfectly possible?
1Division of Palliative Care Medicine, Department of Oncology, University of Alberta, Canada.
Summary
Obese cancer patients can experience muscle depletion (sarcopenia) despite excess weight, which is linked to mortality. This condition, sarcopenic obesity, requires further research and clinical attention for better patient outcomes.
Area of Science:
- Oncology
- Nutrition Science
- Geriatrics
Background:
- Existing definitions of clinically significant weight loss in cancer patients do not adequately address individuals with obesity.
- Obesity is often associated with a survival advantage in advanced cancer stages, contrasting with underweight patients.
Purpose of the Study:
- To explore the clinical impact of weight loss and skeletal muscle mass depletion in obese cancer patients.
- To review the definition and implications of cancer cachexia in the context of obesity.
Main Methods:
- Review of existing literature on cancer-associated weight loss, cachexia, and obesity.
- Analysis of diagnostic imaging techniques for assessing skeletal muscle index (SMI).
Main Results:
- Obese patients with cancer can exhibit significant skeletal muscle depletion (sarcopenia), independent of overall weight loss.
- While weight loss is associated with mortality in obese patients (BMI > 30 kg/m²), the impact is less severe than in normal or underweight individuals.
- Muscle depletion in obese cancer patients strongly correlates with mortality, surgical complications, and treatment toxicity.
Conclusions:
- Concurrent diagnosis of obesity and cachexia presents a paradox but highlights the complexity of nutritional status in cancer.
- Sarcopenic obesity in cancer patients is linked to poor clinical outcomes and warrants further investigation, clinical diagnosis, and targeted interventions.
- The clinical priority of weight loss management may differ between obese and low-body-weight cancer patients.
Related Concept Videos
01:24Obesity
442
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
442
01:28Anorexia Nervosa
58
Anorexia nervosa is a complex and severe eating disorder characterized by an intense fear of weight gain, an unrelenting pursuit of thinness, and a distorted body image. It often leads to dangerously low body weight relative to an individual's age and height. This disorder is marked by significant physical and psychological consequences, making it one of the most life-threatening psychiatric illnesses.
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
58
01:30Assessment of Airway, Skin Color, and Use of Accessory Muscles
986
A thorough assessment of respiratory health is paramount in clinical settings to identify and manage respiratory distress and ensure adequate oxygenation. This article elaborates on the critical aspects of respiratory evaluation, including airway assessment, skin color examination, and the observation of accessory muscle use, which are integral to effectively diagnosing and managing patients with respiratory conditions.
Introduction
The initial evaluation of a patient's respiratory system...
Introduction
The initial evaluation of a patient's respiratory system...
986